Detalhe da pesquisa
1.
TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1.
J Immunol
; 199(12): 4091-4102, 2017 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29127145
2.
Human umbilical tissue-derived cells rescue retinal pigment epithelium dysfunction in retinal degeneration.
Stem Cells
; 34(2): 367-79, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26523756
3.
Characterization of a Novel Bispecific Antibody That Activates T Cells In Vitro and Slows Tumor Growth In Vivo.
Monoclon Antib Immunodiagn Immunother
; 38(6): 242-254, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31825302
4.
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.
Cancer Res
; 63(21): 7483-9, 2003 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14612549
5.
Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4(+) and CD8(+) T Cells.
Front Immunol
; 7: 221, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27379090
6.
Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging.
PLoS One
; 10(12): e0145078, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26674639
7.
CCL22-specific Antibodies Reveal That Engagement of Two Distinct Binding Domains on CCL22 Is Required for CCR4-mediated Function.
Monoclon Antib Immunodiagn Immunother
; 34(6): 373-80, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26683175
8.
Isolation and optimization for affinity and biophysical characteristics of anti-CCL17 antibodies from the VH1-69 germline gene.
Protein Eng Des Sel
; 27(6): 199-206, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24742503
9.
Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
PLoS One
; 8(12): e81465, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24339934
10.
Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
Monoclon Antib Immunodiagn Immunother
; 32(3): 162-71, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23750473